Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jingqin Zhong"'
Autor:
Wenjie Ma, Wanlin Liu, Jingqin Zhong, Zijian Zou, Xinyi Lin, Wei Sun, Tu Hu, Yu Xu, Yong Chen
Publikováno v:
Holistic Integrative Oncology, Vol 3, Iss 1, Pp 1-12 (2024)
Abstract Purpose This review primarily discusses the current research advance of predictive biomarkers for melanoma immunotherapy. The aim of the present review is to summarize the biomarkers and evaluate the advantages and disadvantages. Methods All
Externí odkaz:
https://doaj.org/article/5776f04a3e724f48b12332ec7d570995
Autor:
Chuanyuan Wei, Wei Sun, Kangjie Shen, Jingqin Zhong, Wanlin Liu, Zixu Gao, Yu Xu, Lu Wang, Tu Hu, Ming Ren, Yinlam Li, Yu Zhu, Shaoluan Zheng, Ming Zhu, Rongkui Luo, Yanwen Yang, Yingyong Hou, Fazhi Qi, Yuhong Zhou, Yong Chen, Jianying Gu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract Acral melanoma (AM) is a rare subtype of melanoma characterized by a high incidence of lymph node (LN) metastasis, a critical factor in tumor dissemination and therapeutic decision-making. Here, we employ single-cell and spatial transcriptom
Externí odkaz:
https://doaj.org/article/ee35eeed1e244341a06847f1bd0adb20
Autor:
Jingqin Zhong, Wei Sun, Tu Hu, Chunmeng Wang, Wangjun Yan, Zhiguo Luo, Xin Liu, Yu Xu, Yong Chen
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11475-11482 (2023)
Abstract Background BRAF V600 mutation is the most common oncogenic alternation in melanoma and is visible in around 50% of cutaneous and 10%–15% of acral or mucosal subtypes. Currently, immunotherapy with anti‐PD‐1 blockade and dual‐targeted
Externí odkaz:
https://doaj.org/article/b3199656f93a4f40a0ba6b50873bce70
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Sarcomas are rare, heterogeneous mesenchymal neoplasms with various subtypes, each exhibiting unique genetic characteristics. Although studies have been conducted to improve the treatment for sarcomas, the specific development from normal somatic cel
Externí odkaz:
https://doaj.org/article/d6179ad7ddd84599aac01d167d396014
Autor:
Wei Sun, Yongjia Jin, Chuanyuan Wei, Yu Xu, Wanlin Liu, Jingqin Zhong, Zijian Zou, Xinyi Lin, Yang Xiang, Yong Chen
Publikováno v:
European Journal of Cancer. 188:49-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a3b17d20c01e7703c477d0b04b7ebe0
https://doi.org/10.1016/j.ejca.2023.04.005
https://doi.org/10.1016/j.ejca.2023.04.005
Autor:
Wei Sun, Yu Zhu, Zijian Zou, Lu Wang, Jingqin Zhong, Kangjie Shen, Xinyi Lin, Zixu Gao, Wanlin Liu, Yinlam Li, Yu Xu, Ming Ren, Tu Hu, Chuanyuan Wei, Jianying Gu, Yong Chen
Publikováno v:
Theranostics; 2024, Vol. 14 Issue 5, p2127-2150, 24p
Publikováno v:
Journal of Immunotherapy & Precision Oncology. Aug2024, Vol. 7 Issue 3, p223-223. 1/2p.
Publikováno v:
Journal of Immunotherapy & Precision Oncology. Aug2024, Vol. 7 Issue 3, p222-222. 1/3p.
Autor:
Jingqin Zhong, Zijian Zou, Tu Hu, Wei Sun, Chunmeng Wang, Wangjun Yan, Zhiguo Luo, Xin Liu, Yu Xu, Yong Chen
Background Sentinel node biopsy (SNB) has become a critical part of standard surgical treatment for melanoma with no metastatic evidence. According to MSLT-II and DeCOG-SLT trials, for patients with positive sentinel nodes, immediate complete lymph n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a085d84e13a3e5b10a2986d2b15cf51
https://doi.org/10.21203/rs.3.rs-2888154/v1
https://doi.org/10.21203/rs.3.rs-2888154/v1
Autor:
Jingqin Zhong, Wangjun Yan, Chunmeng Wang, Wanlin Liu, Xinyi Lin, Zijian Zou, Wei Sun, Yong Chen
Publikováno v:
Current Treatment Options in Oncology. 23:1877-1878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b62f1530c697e6e29161de1cedf7854
https://doi.org/10.1007/s11864-022-01038-z
https://doi.org/10.1007/s11864-022-01038-z